Squamous Cells in Urine: Clinical Significance and Management
The presence of squamous cells in urine typically indicates specimen contamination from the distal urethra or perineal/vaginal area, but when present in significant numbers alongside white blood cells or when atypical, they warrant careful evaluation and potentially specimen recollection using a more reliable method. 1
Normal Anatomic Origin
Squamous epithelial cells normally line specific anatomic regions:
- The distal third of the urethra is dominated by squamous epithelium 2
- The trigone area of the bladder contains squamous epithelium 1
- In women, the cervicovaginal region contributes squamous cells 1
Clinical Interpretation Based on Quantity and Context
Benign Squamous Cells (Most Common Scenario)
When numerous squamous cells appear alongside >10 WBCs and mixed bacterial flora, this strongly suggests specimen contamination rather than true infection. 1
- Clean-catch specimens have a 27% contamination rate 1
- Bag specimens have a 65-68% contamination rate 1
- Catheterized specimens have only a 4.7% contamination rate with 95% sensitivity and 99% specificity 1
Proper perineal cleansing before collection reduces contamination rates from 23.9% to 7.8%. 1
Impact on Urinalysis Performance
Squamous cells significantly impair the predictive value of urinalysis for bacteriuria:
- Samples with <8 SECs/low-powered field predict bacteriuria with 75% sensitivity and 84% specificity 3
- Samples with >8 SECs/low-powered field show reduced performance: 86% sensitivity but only 70% specificity 3
- The positive likelihood ratio drops from 4.98 to 2.35 when >8 SECs/lpf are present 3
Importantly, squamous cell count is a poor predictor of urine culture contamination itself (area under ROC curve = 0.680), meaning their presence should not be used to dismiss abnormal culture results. 3
Atypical Squamous Cells: High-Risk Finding
When atypical squamous cells (ASC) are identified—characterized by keratinizing cells with large hyperchromatic nuclei, high nuclear-to-cytoplasmic ratio, and densely orangeophilic cytoplasm—this represents a significant finding with substantial malignancy risk. 4, 5
Risk Stratification for Atypical Squamous Cells
The risk of high-grade malignancy varies by atypia grade and accompanying findings:
- Low-grade squamous atypia alone: 70% risk of high-grade malignancy 5
- High-grade squamous atypia alone: 92% risk of high-grade malignancy 5
- Any ASC with accompanying urothelial cell abnormality: 94% risk of high-grade malignancy 5
- ASC without urothelial abnormality: 37% risk of high-grade malignancy 5
Malignancies Associated with Atypical Squamous Cells
When malignancy is diagnosed following ASC detection, the following are found:
- Squamous cell carcinoma of the bladder (most common) 4
- Urothelial carcinoma with squamous differentiation 4, 5
- High-grade cervical squamous cell carcinoma (6% of cases in women) 4
- Rarely, endometrioid adenocarcinoma of the endometrium with squamous differentiation 6
Notably, 51% of malignancies show only rare atypical squamous cells in urine, so even small numbers warrant attention. 5
Management Algorithm
For Benign-Appearing Squamous Cells
If clinical suspicion for UTI remains high despite numerous squamous cells:
If squamous cells are present with negative urinalysis:
For Atypical Squamous Cells
Any report of atypical squamous cells requires immediate urologic evaluation regardless of quantity. 5
Cystoscopy with biopsy to evaluate for:
In women, pelvic examination with cervical cytology to exclude:
Upper tract imaging if no bladder or cervical source identified 1
The Bethesda System should be used for reporting urine cytology results with appropriate follow-up for epithelial cell abnormalities. 1
Common Pitfalls to Avoid
- Do not dismiss abnormal urine cultures solely based on squamous cell presence, as squamous cells poorly predict culture contamination 3
- Do not assume all squamous cells represent contamination—atypical squamous cells occur in only 0.15-0.3% of specimens but carry high malignancy risk 4, 5
- Do not overlook rare atypical squamous cells, as half of associated malignancies present with only rare cells 5
- In women with ASC, do not skip pelvic examination, as 6% have cervical malignancy 4